KR101192117B1 - Method for manufacturing of fermented ginseng or fermented red ginseng - Google Patents
Method for manufacturing of fermented ginseng or fermented red ginseng Download PDFInfo
- Publication number
- KR101192117B1 KR101192117B1 KR1020110007097A KR20110007097A KR101192117B1 KR 101192117 B1 KR101192117 B1 KR 101192117B1 KR 1020110007097 A KR1020110007097 A KR 1020110007097A KR 20110007097 A KR20110007097 A KR 20110007097A KR 101192117 B1 KR101192117 B1 KR 101192117B1
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- fermented
- red ginseng
- suspension
- mushrooms
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 96
- 241000208340 Araliaceae Species 0.000 title claims abstract description 73
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 73
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 73
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 73
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims description 21
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 51
- 239000000725 suspension Substances 0.000 claims abstract description 49
- 239000008188 pellet Substances 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 28
- 238000005273 aeration Methods 0.000 claims abstract description 19
- 238000012136 culture method Methods 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000001954 sterilising effect Effects 0.000 claims abstract description 14
- 239000012153 distilled water Substances 0.000 claims abstract description 13
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 10
- 238000007664 blowing Methods 0.000 claims abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 6
- 238000000227 grinding Methods 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 22
- 241000233866 Fungi Species 0.000 claims description 10
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 240000008397 Ganoderma lucidum Species 0.000 claims description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 3
- 240000000599 Lentinula edodes Species 0.000 claims description 3
- 240000001462 Pleurotus ostreatus Species 0.000 claims description 3
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims description 3
- 241000124033 Salix Species 0.000 claims description 2
- 241000121220 Tricholoma matsutake Species 0.000 claims description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 229930182494 ginsenoside Natural products 0.000 abstract description 19
- 229940089161 ginsenoside Drugs 0.000 abstract description 15
- 239000002207 metabolite Substances 0.000 abstract description 10
- 230000001766 physiological effect Effects 0.000 abstract description 5
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 description 11
- 201000011510 cancer Diseases 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 239000002253 acid Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 241000190633 Cordyceps Species 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법에 관한 것으로서, 특히 인삼 또는 홍삼을 분쇄하여 인삼분말 또는 홍삼분말을 제조하는 제1단계와; 상기 제1단계에서 제조된 인삼분말 또는 홍삼분말에 증류수를 첨가하여 인삼현탁액 또는 홍삼현탁액을 만든 후 멸균하는 제2단계와; 풀버섯 균사체를 30~35℃의 온도와 100~400rpm을 유지하는 GY(Glucose-Yeast)배지에서 2~5일간 진탕배양하면서 2~10vvm의 공기를 불어넣어 1~10mm의 펠릿균사체로 제조하는 제3단계와; 상기 제2단계에서 멸균되어 생성된 인삼현탁액 또는 홍삼현탁액에 상기 제3단계에서 제조된 펠릿균사체를 접종하고, 30~35℃의 온도에서 pH 4.5~6.5를 유지하면서 2~7일동안 2~10vvm의 공기를 불어넣어 배양하여 발효인삼 배양액 또는 발효홍삼 배양액을 제조하는 제4단계와; 상기 제4단계에서 제조된 발효인삼 배양액 또는 발효홍삼 배양액을 95℃에서 30~60분간 가열하여 살균하는 제5단계와; 상기 제5단계에서 살균된 발효인삼 배양액 또는 발효홍삼 배양액을 농축하는 제6단계;로 구성되어, 단기간 내에 다양한 생리활성을 가진 Rh1, Rh 2, Rg3, Compound K 등의 진세노사이드 대사체를 다량 함유하는 발효인삼 또는 발효홍삼을 제조할 수 있는 효과가 있다.The present invention relates to a method for producing fermented ginseng or fermented red ginseng using aeration pellet culture method, in particular, a first step of preparing ginseng powder or red ginseng powder by grinding ginseng or red ginseng; A second step of sterilizing the ginseng suspension or red ginseng suspension by adding distilled water to the ginseng powder or red ginseng powder prepared in the first step; Preparation of 1 to 10 mm pellet mycelium by blowing 2 ~ 10vvm of air while shaking the culture of grass mushroom mycelium in Glucose-Yeast (GY) medium that maintains temperature of 30 ~ 35 ℃ and 100 ~ 400rpm Step 3; Inoculate the pellet mycelium prepared in the third step to the ginseng suspension or red ginseng suspension produced by sterilization in the second step, while maintaining the pH 4.5 ~ 6.5 at a temperature of 30 ~ 35 ℃ 2 ~ 10vvm A fourth step of preparing a fermented ginseng culture solution or a fermented red ginseng culture solution by injecting air into the culture; A fifth step of sterilizing the fermented ginseng culture solution or the fermented red ginseng culture solution prepared in step 4 by heating at 95 ° C. for 30 to 60 minutes; The sixth step of concentrating the fermented ginseng culture solution or fermented red ginseng culture solution sterilized in the fifth step; consisting of a large amount of ginsenoside metabolites such as Rh1, Rh 2, Rg3, Compound K having various physiological activities in a short period of time There is an effect that can be produced fermented ginseng or fermented red ginseng containing.
Description
본 발명은 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법에 관한 것으로서, 특히 단기간 내에 면역력 증강 및 생리활성을 갖는 진세노사이드 대사체를 다량 함유하는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법에 관한 것이다.
The present invention relates to a method for producing fermented ginseng or fermented red ginseng using aerated pellet culture method, and in particular, a method for preparing fermented ginseng or fermented red ginseng using aerated pellet culture method containing a large amount of ginsenoside metabolites having immunity enhancement and physiological activity within a short period of time. It is about.
인삼은 섭취시 비극성이 높은 알카로이드 등은 위에서 흡수되나, 대부분의 다당체, 사포닌 등은 흡수되지 않는다. 이들은 장내에 서식하는 균주들과 접하게 되고, 이 균주들은 쉽게 이용가능한 당 부분을 분해하여 체내로 흡수하게 된다. 당이 분해되어 흡수되기 쉬운 형태인 진세노사이드 대사체는 이후 혈액 내로 흡수되어 인체에 약효를 발휘하게 된다. 이런 장내세균 전환체 또는 대사체들은 경구투여 되기 전의 사포닌들과 비교해서 대부분이 약효가 상당히 증가된다.When ginseng is ingested, non-polar alkaloids and the like are absorbed in the stomach, but most polysaccharides and saponins are not absorbed. They come in contact with strains that live in the gut, and these strains break down readily available sugar moieties and absorb them into the body. Ginsenoside metabolite, which is a form of sugar that is easily broken down and absorbed, is then absorbed into the blood to exert its effects on the human body. Most of these enterobacterial transformants or metabolites are significantly increased in efficacy compared to saponins prior to oral administration.
인삼의 주성분은 사포닌인 '진세노사이드(ginsenoside)'이며, 프로토페낙사디올(protopanaxadiol)계인 진세노사이드 Rb1, Rb2, Rc 등과 프로토페낙사트리올(protopanaxatriol)계인 진세노사이드 Re, Rg1, Rf 등이 알려져 있는데, 이 성분들의 약리작용으로는 항암활성, 항염증, 항당뇨작용 등이 알려져 있다.The main ingredient of ginseng is 'ginsenoside', a saponin, and ginsenosides Rb1, Rb2 and Rc, which are protopanaxadiols, and ginsenosides Re, Rg1, and Rf, which are protopanaxatriols. The pharmacological action of these ingredients is known, such as anti-cancer activity, anti-inflammatory, anti-diabetic action is known.
따라서, 상기와 같은 다양한 생리활성을 갖는 진세노사이드 대사체를 다량 함유되도록 하기 위해서 종래에 인삼을 배양하는 여러 가지 방법들이 제안되었으나, 종래의 방법들은 그 배양기간이 오래 걸려서 산업화하기에 부적절하거나 진세노사이드가 기대했던 것보다 적은 양이 함유되는 문제점을 갖고 있다.
Therefore, various methods for cultivating ginseng have been proposed in order to contain a large amount of ginsenoside metabolites having various physiological activities as described above. It has a problem that less amount than cenoside expected.
본 발명은 상기한 종래기술의 문제점을 해결하기 위하여 안출된 것으로서, 단기간 내에 면역력 증강, 항종양, 항암효과 등과 같은 다양한 생리활성을 갖는 진세노사이드 대사체를 다량 함유할 수 있는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법을 제공하는데 그 목적이 있다.
The present invention has been made to solve the above problems of the prior art, using aeration pellet culture method that can contain a large amount of ginsenoside metabolites having a variety of physiological activities such as boosting immunity, antitumor, anticancer effect in a short period of time Its purpose is to provide fermented ginseng or fermented red ginseng manufacturing method.
상기한 과제를 해결하기 위한 본 발명에 의한 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법은 인삼 또는 홍삼을 분쇄하여 인삼분말 또는 홍삼분말을 제조하는 제1단계와; 상기 제1단계에서 제조된 인삼분말 또는 홍삼분말에 증류수를 첨가하여 인삼현탁액 또는 홍삼현탁액을 만든 후 멸균하는 제2단계와; 풀버섯 균사체를 30~35℃의 온도와 100~400rpm을 유지하는 GY(Glucose-Yeast)배지에서 2~5일간 진탕배양하면서 2~10vvm의 공기를 불어넣어 1~10mm의 펠릿균사체로 제조하는 제3단계와; 상기 제2단계에서 멸균되어 생성된 인삼현탁액 또는 홍삼현탁액에 상기 제3단계에서 제조된 펠릿균사체를 접종하고, 30~35℃의 온도에서 pH 4.5~6.5를 유지하면서 2~7일동안 2~10vvm의 공기를 불어넣어 배양하여 발효인삼 배양액 또는 발효홍삼 배양액을 제조하는 제4단계와; 상기 제4단계에서 제조된 발효인삼 배양액 또는 발효홍삼 배양액을 95℃에서 30~60분간 가열하여 살균하는 제5단계와; 상기 제5단계에서 살균된 발효인삼 배양액 또는 발효홍삼 배양액을 농축하는 제6단계;로 구성된다. Fermented ginseng or fermented red ginseng production method using a ventilated pellet culture method according to the present invention for solving the above problems is the first step of producing a ginseng powder or red ginseng powder by grinding ginseng or red ginseng; A second step of sterilizing the ginseng suspension or red ginseng suspension by adding distilled water to the ginseng powder or red ginseng powder prepared in the first step; Preparation of 1 to 10 mm pellet mycelium by blowing 2 ~ 10vvm of air while shaking the culture of grass mushroom mycelium in Glucose-Yeast (GY) medium that maintains temperature of 30 ~ 35 ℃ and 100 ~ 400rpm Step 3; Inoculate the pellet mycelium prepared in the third step to the ginseng suspension or red ginseng suspension produced by sterilization in the second step, while maintaining the pH 4.5 ~ 6.5 at a temperature of 30 ~ 35 ℃ 2 ~ 10vvm A fourth step of preparing a fermented ginseng culture solution or a fermented red ginseng culture solution by injecting air into the culture; A fifth step of sterilizing the fermented ginseng culture solution or the fermented red ginseng culture solution prepared in step 4 by heating at 95 ° C. for 30 to 60 minutes; And a sixth step of concentrating the fermented ginseng culture solution or the fermented red ginseng culture solution sterilized in the fifth step.
한편, 상기 제3단계에서 진탕배양할 때 풀버섯 균사체와 함께 담자균류를 추가하여 진탕배양하는데, 상기 담자균류는 구름버섯, 상황버섯, 영지버섯, 꽃송이버섯, 표고버섯, 흰들버섯, 동충하초, 그물버섯, 양송이버섯, 차가버섯, 목이버섯, 버들송이, 만가닥버섯, 느타리버섯 중에서 하나 이상 선택된 것이다.On the other hand, when the shaking culture in the third step by adding a mushroom fungus with grass fungus mycelium shake culture, the fungus mushroom, cloud mushroom, situation mushroom, Ganoderma lucidum mushroom, mushroom mushroom, shiitake mushroom, white mushroom, cordyceps, net At least one selected from mushrooms, mushrooms, chaga, thirsty mushrooms, willows, mandala and oyster mushrooms.
그리고, 상기 제4단계에서는 인삼현탁액 또는 홍삼현탁액의 하측까지 삽입된 공기주입관을 통하여 공기가 인삼현탁액 또는 홍삼현탁액의 하측으로부터 상측을 향하여 주입된다.
In the fourth step, air is injected from the lower side of the ginseng suspension or the red ginseng suspension toward the upper side through the air injection tube inserted to the lower side of the ginseng suspension or the red ginseng suspension.
상기와 같이 구성되는 본 발명의 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법은 면역력 증강, 항종양, 항암효과 등과 같은 다양한 생리활성을 가진 Rh1, Rh 2, Rg3, Compound K 등의 진세노사이드 대사체를 다량 함유하며, 진세노사이드의 체내 섭취율을 현저히 향상시킬 수 있는 이점이 있다.Fermented ginseng or fermented red ginseng production method using the aeration pellet culture method of the present invention is configured as described above ginsenosides such as Rh1, Rh 2, Rg3, Compound K having a variety of physiological activities, such as immunity enhancement, antitumor, anticancer effect, etc. Contains a large amount of metabolites, there is an advantage that can significantly improve the body intake rate of ginsenosides.
또한, 인삼현탁액 또는 홍삼현탁액의 하측으로부터 이루어지는 통기를 통하여 배양일수가 단축되는 이점이 있다.
In addition, there is an advantage that the culture days are shortened through aeration from the bottom of the ginseng suspension or red ginseng suspension.
도 1은 본 발명에 의한 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법을 보인 순서도.
도 2a는 표 2에 기재된 비교예의 진세노사이드 분석 프로파일이고, 도 2b는 표 2에 기재된 실시예의 진세노사이드 분석 프로파일.
도 3의 A는 표 3에 기재된 대조군의 고형암 크기를 보인 도이고, B는 표 3에 기재된 시료투여군의 고형암 크기를 보인 도.1 is a flow chart showing a fermented ginseng or fermented red ginseng manufacturing method using aeration pellet culture method according to the present invention.
FIG. 2A is a ginsenoside analysis profile of the comparative examples listed in Table 2, and FIG. 2B is a ginsenoside analysis profile of the examples described in Table 2. FIG.
Figure 3 A is a diagram showing the solid cancer size of the control group shown in Table 3, B is a diagram showing the solid cancer size of the sample administration group described in Table 3.
이하, 본 발명에 의한 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법의 실시 예를 첨부된 도면을 참조하여 상세히 설명한다.Hereinafter, with reference to the accompanying drawings an embodiment of the fermented ginseng or fermented red ginseng production method using aeration pellet culture method according to the present invention will be described in detail.
도 1은 본 발명에 의한 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법을 보인 순서도이다.1 is a flow chart showing a fermented ginseng or fermented red ginseng manufacturing method using aeration pellet culture method according to the present invention.
그리고, 도 2a는 표 2에 기재된 비교예의 진세노사이드 분석 프로파일이고, 도 2b는 표 2에 기재된 실시예의 진세노사이드 분석 프로파일이다.2A is a ginsenoside analysis profile of the comparative example shown in Table 2, and FIG. 2B is a ginsenoside analysis profile of the example shown in Table 2. FIG.
또한, 도 3의 A는 표 3에 기재된 대조군의 고형암 크기를 보인 도이고, B는 표 3에 기재된 시료투여군의 고형암 크기를 보인 도이다.
In addition, A of Figure 3 is a diagram showing the solid cancer size of the control group shown in Table 3, B is a diagram showing the solid cancer size of the sample administration group described in Table 3.
본 발명에 의한 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법은 몇 단계의 과정을 거쳐 완성된다.Fermented ginseng or fermented red ginseng manufacturing method using aeration pellet culture method according to the present invention is completed through a few steps.
먼저, 제1단계(S10)는 인삼 또는 홍삼을 분쇄하여 인삼분말 또는 홍삼분말을 제조하는 분말화과정이다. 홍삼분말을 예로 들어 좀 더 부연하면, 수삼을 세척하여 찌고 건조하기를 반복하여 수분이 15% 이하로 함유된 홍삼을 준비한 후 홍삼을 분쇄기에 넣고 분말화하는 과정이 제1단계(S10)이다.
First, the first step (S10) is a powdering process for preparing ginseng powder or red ginseng powder by grinding ginseng or red ginseng. Taking red ginseng powder as an example, the first step (S10) is to prepare red ginseng containing 15% or less moisture by washing, steaming and drying the ginseng, and then putting the red ginseng into a grinder.
제2단계(S20)는 상기 제1단계(S10)에서 제조된 인삼분말 또는 홍삼분말에 증류수를 첨가하여 인삼현탁액 또는 홍삼현탁액을 만든 후 이것을 멸균하는 과정이다. 이때, 첨가되는 증류수는 상기 인삼분말 또는 홍삼분말 중량의 2~10배(바람직하게는 4~6배)에 해당되는 양이다. 그리고, 120~125℃를 유지하는 멸균기 안에 인삼현탁액 또는 홍삼현탁액을 15~60분 정도 넣어 놓음으로써 멸균작업을 수행한다.
The second step (S20) is a process of sterilizing the ginseng suspension or red ginseng suspension by adding distilled water to the ginseng powder or red ginseng powder prepared in the first step (S10). At this time, the added distilled water is an amount corresponding to 2 to 10 times (preferably 4 to 6 times) the weight of the ginseng powder or red ginseng powder. Then, the sterilization operation is performed by putting ginseng suspension or red ginseng suspension for about 15 to 60 minutes in a sterilizer maintaining 120 to 125 ° C.
제3단계(S30)는 풀버섯 균사체를 30~35℃의 온도와 100~400rpm의 회전속도를 유지하는 GY(Glucose-Yeast)배지에서 2~5일간 진탕배양하면서 2~10vvm(바람직하게는 3~5vvm)의 공기를 불어넣어 1~10mm의 펠릿균사체로 제조하는 과정이다. 이때, GY(Glucose-Yeast)배지에는 풀버섯 균사체만을 접종하여 통기를 하면서 진탕배양함으로써 펠릿균사체를 제조할 수도 있으나, 풀버섯 균사체와 함게 담자균류를 GY(Glucose-Yeast)배지에 접종하여 진탕배양함으로써 펠릿균사체를 제조할 수도 있다. 여기에서 말하는 담자균류는 구름버섯, 상황버섯, 영지버섯, 꽃송이버섯, 표고버섯, 흰들버섯, 동충하초, 그물버섯, 양송이버섯, 차가버섯, 목이버섯, 버들송이, 만가닥버섯, 느타리버섯 중에서 하나 이상 선택된 버섯균사체를 말하는 것이다.The third step (S30) is 2 ~ 10vvm (preferably 3 3) while shaking the mycelium mycelium shaken for 2-5 days in Glucose-Yeast (GY) medium that maintains the temperature of 30 ~ 35 ℃ and rotation speed of 100 ~ 400rpm It is a process of making pellet mycelium of 1 ~ 10mm by blowing air of ~ 5vvm). At this time, GY (Glucose-Yeast) medium may be inoculated with only the mushroom fungus mycelium and aspirated while shaking to culture pellet pellets, but inoculated with GY (Glucose-Yeast) medium with the mushroom fungus mycelium in a shake culture Pellet mycelium can also be manufactured by doing this. The fungi mentioned here are at least one of cloud mushrooms, situation mushrooms, ganoderma lucidum mushrooms, matsutake mushrooms, shiitake mushrooms, white mushrooms, cordyceps, net mushrooms, mushroom mushrooms, chaga mushrooms, tree mushrooms, willow mushrooms, mandala mushrooms and oyster mushrooms. It refers to the selected mushroom mycelium.
좀 더 부연하면, 상기 제3단계(S30)는 풀버섯 균사체(또는 담자균류와 함께)를 접종한 GY(Glucose-Yeast)배지를 삼각플라스크에 넣고, 이 삼각플라스크를 30~35℃ 유지하면서 100~400rpm으로 회전시킴과 아울러 2~10vvm의 통기를 함으로써 수행되는데, 이때, 통기는 상기 삼각플라스크의 하측에서 상측으로 향하도록 한다. 즉, 삼각플라스크의 하측까지 삽입 연장된 공기주입관에 의하여 외부의 공기가 삼각플라스크의 가장 하측으로 먼저 공급되고, 공급된 공기는 삼각플라스크의 내부 하측에서 상측을 향하여 유동하도록 하는 것이다. 본 명세서에서는 이것을 '통기심부배양'이라 명명하도록 한다.
More specifically, the third step (S30) is a GY (Glucose-Yeast) medium inoculated with grass mushroom mycelium (or biliary fungus) in a Erlenmeyer flask, while maintaining the Erlenmeyer flask at 30 ~ 35 ℃ 100 By rotating at ~ 400rpm and aeration of 2 ~ 10vvm is carried out, at this time, the aeration is directed to the upper side from the lower side of the triangular flask. That is, the outside air is first supplied to the lowest side of the Erlenmeyer flask by the air injection tube inserted and extended to the lower side of the Erlenmeyer flask, and the supplied air flows from the lower side of the Erlenmeyer flask toward the upper side. In this specification, this is referred to as 'breath core culture'.
제4단계(S40)는 상기 제2단계(S20)에서 멸균되어 생성된 인삼현탁액 또는 홍삼현탁액에 상기 제3단계(S30)에서 제조된 펠릿균사체를 접종하고, 30~35℃의 온도에서 pH 4.5~6.5를 유지하면서 2~7일동안 2~10vvm(바람직하게는 3~5vvm)의 공기를 불어넣어 배양하여 발효인삼 배양액 또는 발효홍삼 배양액을 제조하는 과정이다.The fourth step (S40) is inoculated with the pellet mycelium prepared in the third step (S30) to the ginseng suspension or red ginseng suspension produced by sterilization in the second step (S20), pH 4.5 at a temperature of 30 ~ 35 ℃ It is a process of preparing fermented ginseng culture or fermented red ginseng culture by blowing 2 ~ 10vvm (preferably 3 ~ 5vvm) air for 2-7 days while maintaining ~ 6.5.
이때, 상기 인삼현탁액 또는 홍삼현탁액에 접종되는 펠릿균사체는 그 중량이 상기 인삼현탁액 또는 홍삼현탁액 중량의 5~20%이다.At this time, the pellet mycelium inoculated in the ginseng suspension or red ginseng suspension is 5 ~ 20% of the weight of the ginseng suspension or red ginseng suspension.
그리고, 상기 인삼현탁액 또는 홍삼현탁액에 공기를 주입, 즉 통기를 할 때는 인삼현탁액 또는 홍삼현탁액의 하측까지 삽입된 공기주입관을 통하여 공기가 인삼현탁액 또는 홍삼현탁액의 하측으로부터 상측을 향하여 주입된다. 위에서 언급한 것과 같은 '통기심부배양'을 하는 것이다. 이러한 통기심부배양을 위해서 버블배양기 또는 에어리프트 배양기와 같은 통기심부발효가 가능한 배양기를 사용한다. 이렇게 통기심부배양을 하는 이유는 통기심부배양을 하게 되면 그 배양속도가 종래의 다른 어떠한 방법보다도 빨라지기 때문이다.
When the air is injected into the ginseng suspension or the red ginseng suspension, that is, when the air is aerated, air is injected from the lower side of the ginseng suspension or the red ginseng suspension toward the upper side through an air injection tube inserted to the lower side of the ginseng suspension or the red ginseng suspension. It is to carry out 'breath culture' as mentioned above. For such a deep core culture is used a fermentable core fermentation such as bubble incubator or air lift incubator. The reason for such a deep core culture is that the aeration speed is faster than any other conventional methods.
제5단계(S50)는 상기 제4단계(S40)에서 제조된 발효인삼 배양액 또는 발효홍삼 배양액을 95℃에서 30~60분간 가열하여 살균하는 과정이다.
The fifth step (S50) is a process of sterilizing the fermented ginseng culture solution or fermented red ginseng culture solution prepared in the fourth step (S40) by heating at 95 ° C for 30 to 60 minutes.
제6단계(S60)는 상기 제5단계(S50)에서 살균된 발효인삼 배양액 또는 발효홍삼 배양액을 필터링하고 농축기를 사용하여 농축하는 과정이다.
The sixth step (S60) is a process of filtering the fermented ginseng culture solution or fermented red ginseng culture solution sterilized in the fifth step (S50) and concentrating using a concentrator.
지금부터는 상기와 같은 본 발명에 의한 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법의 실시예를 더욱 구체적으로 제시함과 아울러 본 발명 실시예의 특성을 보다 용이하게 파악할 수 있도록 본 발명의 실시예와 비교할 수 있는 비교예를 제시한다.
From now on, the present invention provides a more detailed embodiment of the method of preparing fermented ginseng or fermented red ginseng using the aeration pellet culture method according to the present invention as well as the embodiment of the present invention so that the characteristics of the embodiments of the present invention can be more easily understood. The comparative example which can be compared is shown.
<실시예><Examples>
수삼을 세척하여 찌고 건조하고를 반복하여 수분함량이 15% 이하로 제조된 홍삼을 준비한다. Wash ginseng, steam and dry to prepare red ginseng with less than 15% water content.
그 다음 증포된 홍삼을 분쇄기를 통해 분쇄하여 분말화한다. 분말화된 홍삼 분말 100g에 증류수를 400g 첨가하여 홍삼현탁액을 만들고 pH 6.2으로 조정하여 121도, 15분간 가압 멸균한다.The red ginseng is then pulverized through a grinder and powdered. 100 g of powdered red ginseng powder is added to 400 g of distilled water to make a red ginseng suspension, adjusted to pH 6.2, and sterilized at 121 degrees for 15 minutes.
풀 버섯 균사체를 통기심부배양장치가 되어 있는 500mL삼각플라스크를 이용하여 GY(glucose-yeast)배지에서 33도, 300rpm에서 3일간 진탕 배양하면서 3vvm의 통기를 불어주면서 5mm의 펠릿균사를 제조한다.Using a 500 mL triangular flask equipped with aeration core culture device for the grass mushroom mycelium, 5mm pellet mycelium is prepared while blowing 3vvm aeration while shaking culture for 3 days at 33 ° C and 300rpm in GY (glucose-yeast) medium.
가압 멸균한 홍삼현탁액에 5mm 펠릿형태로 전배양한 풀 버섯 균사체를 총 무게 함량의 10%수준으로 접종한 다음, 33도에서 통기수준 3vvm, 초기 pH 6.2 조건으로 통기심부배양을 7일간 실시하였다.The inoculated sterilized grass mushroom mycelium pre-cultivated in the form of 5mm pellets at 10% of the total weight of the red ginseng suspension was sterilized under pressure sterilization at 3 ° C and initial pH 6.2 at 33 ° C for 7 days.
상기 과정으로 제조한 발효홍삼 배양액을 95도에서 30분간 가열살균한 뒤에 발효홍삼 배양액에 80% 에탄올 500mL을 가하여 3시간 동안 환류하여 진세노사이드를 추출하였으며 이 환류액을 50mL까지 농축하였다.
The fermented red ginseng culture prepared in the above process was heat sterilized at 95 ° C. for 30 minutes, and 500 mL of 80% ethanol was added to the fermented red ginseng culture to reflux for 3 hours to extract ginsenoside, and the reflux was concentrated to 50 mL.
<비교예>Comparative Example
상기 <실시예>에서 홍삼 현탁액에 풀버섯 균사체를 처리하지 않은 것을 제외하고는 상기 <실시예>와 동일한 방법으로 실시하였다.
The red ginseng suspension in <Example> was carried out in the same manner as in <Example>, except that the green mushroom mycelium was not treated.
<시험예 1> 홍삼분말을 이용한 발효홍삼 배양액의 pH, 총당함량, 산성당(우론산) 함량 측정<Test Example 1> pH, total sugar content, acidic sugar (uronic acid) content of fermented red ginseng culture solution using red ginseng powder
상기 실시예의 발효홍삼 배양액 및 비교예의 홍삼현탁액의 pH, 총당 및 산성당 함량을 다음과 같은 방법으로 측정하고, 그 결과를 하기 표 1에 나타내었다. 먼저, pH는 pH자동측정기를 통해 측정하였고, 총당은 phenolsulfuric acid법으로 측정하였으며, 산성당(우론산)의 함량은 Blumenkrantz과 AsboeHansen법(Blumenkrantz, N.and AsoeHansen, G. (1973) Anal. Biochem., 54, 484)에 의해 측정하였다.The pH, total sugar and acidic sugar content of the fermented red ginseng culture solution of the Example and the red ginseng suspension of the comparative example were measured by the following method, and the results are shown in Table 1 below. First, pH was measured by pH automatic measuring device, total sugar was measured by phenolsulfuric acid method, acidic sugar (uronic acid) content of Blumenkrantz and AsboeHansen method (Blumenkrantz, N.and AsoeHansen, G. (1973) Anal.Biochem , 54, 484).
(mg/mL)Total sugar content
(mg / mL)
(ug/mL)Uronic acid
(ug / mL)
(mg/mL)Total sugar content
(mg / mL)
(ug/mL)Uronic acid
(ug / mL)
상기 표1에 나타낸 바와 같이 풀버섯 균사체를 이용하여 7일간 발효/배양을 한 <실시예>의 경우에 pH는 6.2에서 5.1로 감소하였고, 총당함량은 453mg/mL에서 135mg/mL로 감소하였으며, 우론산은 225ug/mL에서 322ug/mL로 증가하였다. 여기서, 발효가 진행되면서 총당함량이 감소한 것은 발효에 관여하는 버섯균사체 생육에 필요한 탄소원으로 홍삼현탁액의 당이 이용되었음을 보여주는 결과이다. 그리고, 홍삼에 함유된 산성당은 항암 등 면역활성물질로 알려져 있으므로, 발효가 진행되면서 산성당 결합물인 우론산이 증가하는 것은 바람직한 현상이다.As shown in Table 1, the pH was reduced from 6.2 to 5.1, and the total sugar content was reduced from 453 mg / mL to 135 mg / mL in the case of <Example>, which was fermented / cultivated for 7 days using the grass mushroom mycelium. Uronic acid increased from 225 ug / mL to 322 ug / mL. Here, the decrease in the total sugar content as the fermentation proceeds is a result showing that the sugar of red ginseng suspension was used as a carbon source necessary for the growth of mushroom mycelium involved in fermentation. In addition, since the acid sugar contained in red ginseng is known as an immunoactive substance such as anti-cancer, it is preferable that the acidic sugar conjugate uronic acid increases as the fermentation progresses.
이에 반해, <비교예>는 풀버섯 균사체를 처리하지 않았으므로 발효/배양이 전혀 진행되지 않아서 일주일이 지난 후에도 pH, 총당함량 및 우론산의 함량에 변화가 없다.
In contrast, <Comparative Example> did not process the grass mushroom mycelium, so fermentation / cultivation did not proceed at all, so there was no change in pH, total sugar content and uronic acid content even after one week.
<시험예 2> 홍삼분말을 이용한 발효홍삼 배양액의 총 진세노사이드 함량 및 대사체 함량 측정Test Example 2 Measurement of Total Ginsenoside Content and Metabolite Content of Fermented Red Ginseng Culture Solution Using Red Ginseng Powder
홍삼분말을 이용하여 상기 실시예 및 비교예의 발효홍삼 배양액의 총 진세노사이드 함량 및 대사체 함량을 측정하였다. 상시 실시예 및 비교예의 발효홍삼 배양액의 진세노사이드 분석을 위하여 HPLC를 사용하여 다음과 같은 방법에 의해 분석하고, 그 결과를 표 2에 나타내었다.Using ginseng powder, the total ginsenoside content and metabolite content of the fermented red ginseng culture medium of the Examples and Comparative Examples were measured. For ginsenoside analysis of the fermented red ginseng culture solution of the regular examples and comparative examples were analyzed by the following method using HPLC, and the results are shown in Table 2.
분석방법을 좀 더 자세히 설명하면, 상기 실시예의 발효홍삼 배양액 및 비교예의 홍삼현탁액 10g을 각각 평량한 후 80% 에탄올 50mL를 가하여 80℃의 진탕 배양기에서 2회 추출하고, Whatman #1 paper를 이용하여 여과하였다. 이 여과액을 진공농축기를 이용하여 감압 건조하고 50㎖의 증류수를 가하여 용해하였다. To explain the analysis in more detail, after weighing 10 g of the fermented red ginseng culture solution of the Example and the red ginseng suspension of the comparative example, respectively, 50 mL of 80% ethanol was added and extracted twice in a shaker at 80 ° C., using Whatman # 1 paper. Filtered. The filtrate was dried under reduced pressure using a vacuum condenser and dissolved by adding 50 ml of distilled water.
그런 다음 증류수가 가해진 여과액 1㎖에 디에틸에테르 2㎖을 가하여 혼합한 후, 1500rpm에서 10분간 원심분리하여 디에틸에테르를 제거하고, 여기에 다시 불포화 부탄올을 1.5㎖를 가하여 혼합한 다음 부탄올층을 회수하였다. 3회 재 반복하여 회수한 부탄올층에 증류수 1.5㎖을 가하여 혼합하고 원심분리하여 물층을 제거하였으며, 이같은 조작을 2회 재반복하여 수용성 불순물을 세척하였다. Then, 2 ml of diethyl ether was added and mixed with 1 ml of distilled water, and the mixture was centrifuged at 1500 rpm for 10 minutes to remove diethyl ether. Then, 1.5 ml of unsaturated butanol was added thereto, followed by mixing. Was recovered. 1.5 mL of distilled water was added to the recovered butanol layer, which was collected by repetition three times, and the mixture was centrifuged to remove the water layer.
이렇게 얻어진 부탄올층을 40℃에서 건조하였으며, 여기에 메탄올 0.5㎖을 가한 후, 0.45㎛ 멤브레인 필터로 여과하여 HPLC 분석용 시료로 사용하였다.The butanol layer thus obtained was dried at 40 ° C., 0.5 ml of methanol was added thereto, and then filtered through a 0.45 μm membrane filter to use as a sample for HPLC analysis.
HPLC 분석을 함에 있어서, 컬럼(column)은 C18(250 X 4.6mm)이 장착된 Waters Breeze system HPLC를 사용하였고 이동상은 아세토니트릴(Sol. A, HPLC급, Sigma사)과 증류수(Sol. B, HPLC급)를 사용하였으며 검출기는 ELSD detector를 사용하였다. 컬럼 온도는 상온에서 유속은 분당 1.0mL, UV 파장은 203nm로 설정하여 측정하였다.In HPLC analysis, the column was used for Waters Breeze system HPLC equipped with C18 (250 X 4.6 mm) and the mobile phase was acetonitrile (Sol. A, HPLC grade, Sigma) and distilled water (Sol. B, HPLC grade) was used and the detector was an ELSD detector. The column temperature was measured by setting the flow rate at 1.0 mL / min and the UV wavelength at 203 nm at room temperature.
<시험예 3> 홍삼분말을 이용한 발효홍삼 배양액의 면역효과<Test Example 3> Immune effect of fermented red ginseng broth using red ginseng powder
홍삼분말을 이용한 발효홍삼 배양액의 진세노사이드 대사체인 Compound K, Rg3, Rh1, Rh2는 암예방 및 암세포 성장 억제작용을 하는 것으로 알려져 있는데 풀버섯 균주로 발효한 홍삼현탁액의 면역효과를 알아보고자 실험하였다.Compound K, Rg3, Rh1, and Rh2, which are known as ginsenoside metabolites in fermented red ginseng broth using red ginseng powder, are known to prevent cancer and inhibit the growth of cancer cells. The purpose of this study was to investigate the immune effects of red ginseng suspension fermented with grass mushroom strains. .
실험동물은 ICR계 마우스를 바이오링크로부터 분양받아 사료와 물을 자유롭게 공급하면서 동물실험실에서 적응 시킨 후, 건강상태가 양호한 마우스를 사용하였다. 실험동물의 온도는 23ㅁ1℃, 습도는 55ㅁ5%였으며 사료는 펠렛형 실험동물 사료로 하였다. 암세포주는 Sarcoma-180세포를 8-12주령된 ICR마우스의 복강에서 계대 배양한 복강액을 1ml 주사기로 찔러 노란색의 복수액 1ml를 채취한 후, 그 원액을 0.1ml씩 정상 ICR마우스의 복강속에 접종하고 28일간 사육하였다. 시료 투여는 대조군과 시료 투여군으로 나누어 진행하였다. 대조군은 증류수 일정량을 2주 동안 매일 경구 투여하였으며, 시료 투여군은 풀버섯 균사체에 의해 발효 전환된 발효홍삼 배양액을 200mg/kg/day의 농도로 증류수에 완전히 용해시켜 매일 동일량의 농도로 경구투여 하였다. Sarcoma-180 고형암에 대한 항암효과 측정은 28일 후 마우스의 고형암을 적출하고 무게를 microbalance로 측정하였다. 고형암 증식에 대한 저해율은 다음과 같이 계산하고, 그 결과를 표 3에 기재하였다.Experimental animals received ICR mice from Biolink and adapted them in animal laboratories while feeding and feeding water freely. The experimental animals had a temperature of 23 ㅁ 1 ℃ and a humidity of 55 ㅁ 5%. The feed was pellet-type experimental animal feed. The cancer cell line was inoculated with Sarcoma-180 cells in the abdominal cavity of 8-12-week-old ICR mice with a 1 ml syringe, and 1 ml of yellow ascites was collected. The stock solution was then inoculated into the normal ICR mice by 0.1 ml. It was raised for 28 days. Sample administration was divided into a control group and a sample administration group. The control group was orally administered a fixed amount of distilled water daily for 2 weeks, and the sample-administered group was completely dissolved in fermented red ginseng culture solution at 200 mg / kg / day in distilled water and orally administered at the same daily concentration. . The anticancer effect of Sarcoma-180 solid cancer was measured 28 days after the solid cancer of the mouse was extracted and the weight was measured by microbalance. Inhibition rate for solid cancer proliferation was calculated as follows, and the results are shown in Table 3.
저해율(%) = (1- 시료투여군의 암세포 무게/대조군의 암세포 무게) X 100
% Inhibition = (1-Cancer cell weight in control group / cancer cell weight in control group) X 100
S10: 제1단계 S20: 제2단계
S30: 제3단계 S40: 제4단계
S50: 제5단계 S60: 제6단계S10: First step S20: Second step
S30: third step S40: fourth step
S50: fifth step S60: sixth step
Claims (7)
상기 제1단계(S10)에서 제조된 인삼분말 또는 홍삼분말에 증류수를 첨가하여 인삼현탁액 또는 홍삼현탁액을 만든 후 멸균하는 제2단계(S20)와;
풀버섯 균사체를 30~35℃의 온도와 100~400rpm을 유지하는 GY(Glucose-Yeast)배지에서 2~5일간 진탕배양하면서 2~10vvm의 공기를 불어넣어 1~10mm의 펠릿균사체로 제조하는 제3단계(S30)와;
상기 제2단계(S20)에서 멸균되어 생성된 인삼현탁액 또는 홍삼현탁액에 상기 제3단계(S30)에서 제조된 펠릿균사체를 접종하고, 30~35℃의 온도에서 pH 4.5~6.5를 유지하면서 2~7일동안 2~10vvm의 공기를 불어넣어 배양하여 발효인삼 배양액 또는 발효홍삼 배양액을 제조하는 제4단계(S40)와;
상기 제4단계(S40)에서 제조된 발효인삼 배양액 또는 발효홍삼 배양액을 95℃에서 30~60분간 가열하여 살균하는 제5단계(S50)와;
상기 제5단계(S50)에서 살균된 발효인삼 배양액 또는 발효홍삼 배양액을 농축하는 제6단계(S60);로 구성된 것을 특징으로 하는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법.
A first step (S10) of preparing ginseng powder or red ginseng powder by grinding ginseng or red ginseng;
A second step (S20) of sterilizing after making ginseng suspension or red ginseng suspension by adding distilled water to the ginseng powder or red ginseng powder prepared in the first step (S10);
Preparation of 1 to 10 mm pellet mycelium by blowing 2 ~ 10vvm of air while shaking the culture of grass mushroom mycelium in Glucose-Yeast (GY) medium that maintains temperature of 30 ~ 35 ℃ and 100 ~ 400rpm Step 3 (S30) and;
Inoculate the pellet mycelium prepared in the third step (S30) to the ginseng suspension or red ginseng suspension produced by sterilization in the second step (S20), while maintaining the pH 4.5 ~ 6.5 at a temperature of 30 ~ 35 ℃ A fourth step (S40) of preparing a fermented ginseng culture solution or fermented red ginseng culture solution by incubating the air for 2 to 10 vvm for 7 days;
A fifth step (S50) of sterilizing the fermented ginseng culture solution or the fermented red ginseng culture solution prepared in the fourth step (S40) by heating at 95 ° C. for 30 to 60 minutes;
Fermented ginseng or fermented red ginseng using the aeration pellet culture method, characterized in that consisting of; sixth step (S60) to concentrate the fermented ginseng culture solution or fermented red ginseng culture solution sterilized in the fifth step (S50).
상기 제3단계(S30)에서 진탕배양할 때 풀버섯 균사체와 함께 담자균류를 추가하여 진탕배양하는 것을 특징으로 하는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법.
The method according to claim 1,
Fermented ginseng or fermented red ginseng production method using aeration pellet culture method characterized in that the shaking culture in addition to the fungi mushroom mycelium and shaker fungi when the shaking in the third step (S30).
상기 담자균류는 구름버섯, 상황버섯, 영지버섯, 꽃송이버섯, 표고버섯, 흰들버섯, 동충하초, 그물버섯, 양송이버섯, 차가버섯, 목이버섯, 버들송이, 만가닥버섯, 느타리버섯 중에서 선택된 하나 이상의 버섯균사체인 것을 특징으로 하는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법.
The method according to claim 2,
The fungus is one or more mushrooms selected from cloud mushrooms, situation mushrooms, ganoderma lucidum mushrooms, matsutake mushrooms, shiitake mushrooms, white mushrooms, Cordyceps sinensis, net mushrooms, mushroom mushrooms, chaga mushrooms, tree mushrooms, willow mushrooms, mandala mushrooms and oyster mushrooms Fermented ginseng or fermented red ginseng production method using aerated pellet culture method characterized in that the mycelium.
상기 제2단계(S20)에서 첨가되는 증류수는 그 중량이 상기 인삼분말 또는 홍삼분말의 중량에 대하여 2~10배인 것을 특징으로 하는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법.
The method according to claim 1,
The distilled water added in the second step (S20) is the weight of the ginseng powder or red ginseng powder fermented ginseng or fermented red ginseng production method using aeration pellet culture method, characterized in that 2 to 10 times the weight of the powder.
상기 제4단계(S40)에서 인삼현탁액 또는 홍삼현탁액에 접종되는 펠릿균사체는 그 중량이 상기 인삼현탁액 또는 홍삼현탁액의 중량에 대하여 5~20%인 것을 특징으로 하는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법.
The method according to claim 1,
The pellet mycelium inoculated in ginseng suspension or red ginseng suspension in the fourth step (S40) is 5 to 20% by weight of the ginseng suspension or red ginseng suspension, fermented ginseng or fermentation using aerated pellet culture method Red ginseng manufacturing method.
상기 제3단계(S30)에서는 GY(Glucose-Yeast)배지를 삼각플라스크에 넣어 진탕배양을 하면서 외부의 공기를 불어 넣되,
외부의 공기는 삼각플라스크의 하측까지 삽입 연장된 공기주입관에 의하여 삼각플라스크의 하측으로부터 상측으로 유동되는 것을 특징으로 하는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법.
The method according to claim 1,
In the third step (S30) while putting a GY (Glucose-Yeast) medium into the Erlenmeyer flask to shake culture, while blowing the outside air,
External air is fermented ginseng or fermented red ginseng manufacturing method using aeration pellet culture method characterized in that the flow from the lower side to the upper side of the triangular flask by the air injection tube inserted into the lower side of the Erlenmeyer flask.
상기 제4단계(S40)에서는 인삼현탁액 또는 홍삼현탁액의 하측까지 삽입된 공기주입관을 통하여 공기가 인삼현탁액 또는 홍삼현탁액의 하측으로부터 상측을 향하여 주입되는 것을 특징으로 하는 통기펠렛배양법을 이용한 발효인삼 또는 발효홍삼 제조방법.The method according to claim 1,
In the fourth step (S40) through the air injection tube inserted to the lower side of the ginseng suspension or red ginseng suspension fermented ginseng using aeration pellet culture method characterized in that the air is injected from the lower side to the upper side of the ginseng suspension or red ginseng suspension Fermented red ginseng manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110007097A KR101192117B1 (en) | 2011-01-25 | 2011-01-25 | Method for manufacturing of fermented ginseng or fermented red ginseng |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110007097A KR101192117B1 (en) | 2011-01-25 | 2011-01-25 | Method for manufacturing of fermented ginseng or fermented red ginseng |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120085956A KR20120085956A (en) | 2012-08-02 |
KR101192117B1 true KR101192117B1 (en) | 2012-10-17 |
Family
ID=46871902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110007097A KR101192117B1 (en) | 2011-01-25 | 2011-01-25 | Method for manufacturing of fermented ginseng or fermented red ginseng |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101192117B1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101345735B1 (en) * | 2013-10-11 | 2013-12-30 | 주식회사 아미코스메틱 | Cosmetic composition with the extract of ginseng berry fermented with pleurotus ferulae |
KR101705973B1 (en) | 2015-04-22 | 2017-02-13 | 연세대학교 산학협력단 | Electromagnetic wave shileding dielectric film |
CN105123259A (en) * | 2015-07-21 | 2015-12-09 | 石文刚 | Wild imitation cultivation method for toadstool |
KR102448039B1 (en) * | 2022-07-22 | 2022-09-26 | 채희원 | A method of manufacturing powder and extract by complex fermentation with red ginseng and ginseng with excellent medicinal properties using mycelium extracted from various mushrooms |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100945586B1 (en) | 2009-07-14 | 2010-03-08 | (주)새롬바이오 | Method for preparing of fermented ginseng or fermented red ginseng containing ginsenoside metabolites fermented by phellinus linteus having various physiological activity |
KR100945587B1 (en) | 2009-07-14 | 2010-03-08 | (주)새롬바이오 | Method for preparing of fermented ginseng or fermented red ginseng containing ginsenoside metabolites fermented by cordyceps militaris having various physiological activity |
-
2011
- 2011-01-25 KR KR1020110007097A patent/KR101192117B1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100945586B1 (en) | 2009-07-14 | 2010-03-08 | (주)새롬바이오 | Method for preparing of fermented ginseng or fermented red ginseng containing ginsenoside metabolites fermented by phellinus linteus having various physiological activity |
KR100945587B1 (en) | 2009-07-14 | 2010-03-08 | (주)새롬바이오 | Method for preparing of fermented ginseng or fermented red ginseng containing ginsenoside metabolites fermented by cordyceps militaris having various physiological activity |
Also Published As
Publication number | Publication date |
---|---|
KR20120085956A (en) | 2012-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101269410B1 (en) | Methods of culturing Inonotus obliquus, Phellinus linteus, Ganoderma lucidum, Sparassis crispa and Vegetable Worms using mushroom media | |
KR101773081B1 (en) | Dolwoe fermented extracts comprising saponins as an active functional food ingredient and preparation method thereof | |
KR101192117B1 (en) | Method for manufacturing of fermented ginseng or fermented red ginseng | |
CN108836969B (en) | Anticancer red ginseng and preparation method and application thereof | |
DE102015120353A1 (en) | Pharmaceutical composition for the support of chemotherapy drugs and their use | |
US20210403606A1 (en) | Method for separating and purifying polysaccharides from ganoderma spores | |
KR20060121576A (en) | A crude exopolysaccharides produced from phellinus baumii mycellium having hypoglycemic activity and preparation method thereof | |
CN111053803B (en) | Composition with anti-staphylococcus aureus effect and preparation method and application thereof | |
CN103315359B (en) | Grifola frondosus solid state fermentation functional beverage and its preparation method | |
CN100574768C (en) | A kind of anticancer pharmaceutical composition and its production and use | |
CN104013636A (en) | Anti-tumor pharmaceutical use of pentacyclic triterpene saponin compounds of szechuan melandium root | |
US11866692B2 (en) | Fermentation fungal substance of astragalus membranaceus paecilomyces cicadae and its use | |
CN1775267A (en) | Kaikoujian extract, Its preparing method and use | |
CN104491048B (en) | A kind of loquat leaf total sesquiterpene glucoside extract and preparation method and application | |
JP2008212137A (en) | Method for producing new gisenoside from ginseng by liquid culture of phellinus linteus mycelium utilizing biotransformation method | |
CN1977885A (en) | Antihepatitis medicinal composition | |
CN1861104A (en) | Inula flower extractive used to breat diabets mellitus and hyperlipidemia | |
CN108586626A (en) | A kind of preparation method and applications of radix tetrastigme oligosaccharide | |
CN107893035A (en) | A kind of culture medium of Hericium erinaceus, sealwort bioconversion mycelium, the mycelial extract of sealwort bioconversion and application thereof | |
CN100571721C (en) | Long stalk Fructus Schisandrae Sphenantherae extract, Preparation Method And The Use | |
CN1686490A (en) | Chinese medicinal composition, its preparation method and quality control method | |
CN108969580B (en) | Preparation method and application of blue cloth total tannin | |
CN102178701A (en) | Preparation method of polysaccharide composite with antitumor activity | |
CN101564052B (en) | Preparation method of aqua for preventing and controlling sclerotia rot of colza | |
TW202017578A (en) | Preparation method and pharmaceutical composition for the extarct and composition of antrodia cinnamomea. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |